The fungus Agaricus brasiliensis is a Basidiomycete studied because of its immunomodulation and/or antitumor substances. The objective of this study was to verify the Agaricus brasiliensis antineoplasic activity in vivo on different basidiocarp maturation phases on Sarcoma 180 cells implanted in mice.
INTRODUCTION

Agaricus brasiliensis Wasser et al. (A. blazei Murrill ss.
Heinemann) (25) , also denoted A. subrufescens Peck (10) , is a Basidiomycete that has been reported because of its antitumoral substances (2, 9, 16) . Reports 
MATERIALS AND METHODS
The research was approved by the Animal Ethics 
RESULTS AND DISCUSSION
One mouse in the Closed group and two mice in the Opened group did not show any subcutaneous tumoral mass, thus they were not considered in the experiment. Results of the splenic index and tumoral mass (width, length and volume) are shown in Table 1 . on Closed group and 87.64% on Opened group, with average of 89.22% between them. Based on these data closed caps have the same biological activity than opened caps. Thus the claim in the Brazilian market about higher prices for closed caps based on higher biological activity has no confirmation on this study. However other commercial advantages related to sensory and processing characteristics remains for that choice. Another relevant aspect is that because there is no difference of active principle concentration between closed and opened caps it is suggest that the main active principle is not concentrated in spores as occurs in Ganoderma lucidum (13) . Thus the production of vegetative mycelium in liquid medium is likely to be more advantageous for active principle production in large scale than basidiocarps. 
